The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Patton John Stuart since 2005.
The trader's CIK number is 1247653.
At the time of the last reporting, Patton John Stuart was the Chief Scientific Off of Halozyme Therapeutics, Inc.. (stock ticker symbol HALO).
Also see all insider trading activities at Halozyme Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | HALO | 0 | $0 | 75,000 | $747,000 | 75,000 | $153,750 |
| 2013 | HALO | 0 | $0 | 75,000 | $685,049 | 100,000 | $39,000 |
| 2007 | HALO | 0 | $0 | 362,471 | $3,320,215 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | NKTR | 0 | $0 | 760 | $3,321 | 2,500 | $0 |
| 2007 | NKTR | 0 | $0 | 0 | $0 | 30,000 | $401,160 |
| 2006 | NKTR | 0 | $0 | 45,492 | $950,390 | 58,000 | $1,121,727 |
| 2005 | NKTR | 0 | $0 | 1,750 | $25,322 | 0 | $0 |
1. Halozyme Therapeutics, Inc. (HALO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-08-19 | HALO | Option Ex | 75,000 | 2.05 | 153,750 |
| 2014-08-19 | HALO | Sale | 75,000 | 9.96 | 747,000 |
| 2013-09-13 | HALO | Option Ex | 100,000 | .39 | 39,000 |
| 2013-09-13 | HALO | Sale | 37,500 | 9.10 | 341,362 |
| 2013-09-16 | HALO | Sale | 37,500 | 9.16 | 343,687 |
| 2007-10-16 | HALO | Sale | 15,000 | 9.02 | 135,300 |
| 2007-10-09 | HALO | Sale | 15,000 | 8.70 | 130,440 |
| 2007-10-02 | HALO | Sale | 15,000 | 8.89 | 133,425 |
| 2007-09-25 | HALO | Sale | 15,000 | 8.94 | 134,160 |
| 2007-09-18 | HALO | Sale | 17,471 | 8.89 | 155,352 |
| 2007-07-10 | HALO | Sale | 20,000 | 9.78 | 195,560 |
| 2007-06-26 | HALO | Sale | 11,800 | 8.68 | 102,400 |
| 2007-06-26 | HALO | Sale | 8,200 | 8.99 | 73,726 |
| 2007-06-19 | HALO | Sale | 20,000 | 10.28 | 205,600 |
| 2007-06-12 | HALO | Sale | 20,000 | 10.09 | 201,860 |
| 2007-05-29 | HALO | Sale | 20,000 | 10.30 | 206,100 |
| 2007-05-23 | HALO | Sale | 15,000 | 10.52 | 157,800 |
| 2007-05-22 | HALO | Sale | 20,000 | 10.53 | 210,539 |
| 2007-04-18 | HTI | Sale | 25,000 | 9.13 | 228,350 |
| 2007-04-11 | HTI | Sale | 25,000 | 8.61 | 215,300 |
| 2007-04-04 | HTI | Sale | 25,000 | 8.35 | 208,750 |
| 2007-03-28 | HTI | Sale | 25,000 | 8.40 | 209,950 |
| 2007-03-21 | HTI | Sale | 25,000 | 8.61 | 215,275 |
| 2007-03-14 | HTI | Sale | 16,400 | 8.02 | 131,528 |
| 2007-03-15 | HTI | Sale | 8,600 | 8.00 | 68,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-11-14 | NKTR | Option Ex | 2,500 | .00 | 0 |
| 2008-11-14 | NKTR | Sale | 760 | 4.37 | 3,321 |
| 2007-01-26 | NKTR | Option Ex | 14,000 | 13.29 | 186,060 |
| 2007-01-05 | NKTR | Option Ex | 1,000 | 14.52 | 14,520 |
| 2007-01-26 | NKTR | Option Ex | 14,000 | 13.29 | 186,060 |
| 2007-01-05 | NKTR | Option Ex | 1,000 | 14.52 | 14,520 |
| 2006-05-15 | NKTR | Sale | 1,633 | 20.21 | 33,002 |
| 2006-03-07 | NKTR | Sale | 3,859 | 19.80 | 76,388 |
| 2006-01-27 | NKTR | Sale | 20,000 | 22.00 | 440,000 |
| 2006-01-18 | NKTR | Option Ex | 34,645 | 19.32 | 669,341 |
| 2006-01-19 | NKTR | Option Ex | 23,355 | 19.37 | 452,386 |
| 2006-01-13 | NKTR | Sale | 20,000 | 20.05 | 401,000 |
| 2005-05-10 | NKTR | Sale | 1,750 | 14.47 | 25,322 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patton John Stuart (Chief Scientific Off of Halozyme Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.